New Pharmacokinetic (PK) and Pharmacodynamic Data from Sub-Study in Phase III Trial Strengthens Scientific Basis for RenovoRx ...

Complete elimination of Human Immunodeficiency Virus (HIV) presents a challenge due to latent viral reservoirs within the body that can help re-establish infection. In a new paper, researchers propose ...

A new mathematical model that uses drug-target kinetics to predict how drugs work in vivo may provide a foundation to improve drug discovery, which is frequently hampered by the inability to predict ...

The process of developing new drugs is both difficult and costly. It is estimated that of all the drug candidates which start out on their testing journey, less than 14% actually make it to the ...

Drug Pharmacokinetics and Pharmacodynamics (PKPD) has become increasingly critical as drug discovery modalities continue to expand across a broader and more diverse therapeutic landscape. Viva Biotech ...

Our MSc Model-based Drug Development course provides the knowledge and skills in pharmacokinetics and pharmacodynamics for making evidence-based decisions at various stages of drug development. It is ...

Clinical Infectious Diseases, Vol. 45, Supplement 2. Annual Conference on Antimicrobial Resistance (Sep. 1, 2007), pp. S129-S136 (8 pages) The worldwide increase in antibiotic resistance is a concern ...

37 million people around the world today live with Human Immunodeficiency Virus (HIV), which is responsible for roughly 1.1 million deaths caused by AIDS-related conditions. The virus replicates by ...

Explore our campus, meet lecturers and current students, and learn more about what it's like to study at Manchester. Qualify as a mathematical modeller with key skills in computational approaches in ...